StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Methyl iodide → N-(4-iso-propylbenzenesulfonyl)-alpha-(2-n-propy-4-methoxycarbonylphenoxy)-alpha-methyl-3,4-methylenedioxyphenylacetamide

HRID 1378849
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 1378849
[CH:1]([C:4]1[CH:9]=[CH:8][C:7]([S:10]([NH:13][C:14](=[O:39])[CH:15]([C:30]2[CH:35]=[CH:34][C:33]3[O:36][CH2:37][O:38][C:32]=3[CH:31]=2)[O:16][C:17]2[CH:22]=[CH:21][C:20]([C:23]([O:25][CH3:26])=[O:24])=[CH:19][C:18]=2[CH2:27][CH2:28][CH3:29])(=[O:12])=[O:11])=[CH:6][CH:5]=1)([CH3:3])[CH3:2].[CH3:40][Si]([NH-])(C)C.C[Si]([NH-])(C)C.[Li+].[Li+].IC>C1COCC1>[CH:1]([C:4]1[CH:5]=[CH:6][C:7]([S:10]([NH:13][C:14](=[O:39])[C:15]([C:30]2[CH:35]=[CH:34][C:33]3[O:36][CH2:37][O:38][C:32]=3[CH:31]=2)([O:16][C:17]2[CH:22]=[CH:21][C:20]([C:23]([O:25][CH3:26])=[O:24])=[CH:19][C:18]=2[CH2:27][CH2:28][CH3:29])[CH3:40])(=[O:12])=[O:11])=[CH:8][CH:9]=1)([CH3:2])[CH3:3]
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

5

Edukt 3

HCID 6328Methyl iodideHCID 15383771N-(4-iso-propylbenzenesulfonyl)-alpha-(4-carbomethoxy-2-n-propylphenoxy)-3,4-methylenedioxyphenylacetamideHCID 86588160Lithim bis(trimethylsilylamide)

Produkt 1

HCID 19080425N-(4-iso-propylbenzenesulfonyl)-alpha-(2-n-propy-4-methoxycarbonylphenoxy)-alpha-methyl-3,4-methylenedioxyphenylacetamideAusbeute 55 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 8028TetrahydrofuranLösungsmittel2×

Reaktionsbedingungen

Temperatur
-78 °C

Versuchsvorschrift

To a solution of 0.516 g (0.93 mmol) of the product of Example 57 dissolved in 1.0 mL of anhydrous THF was added 2.80 mL (2.80 mmol) of a 1.0M solution of lithim bis(trimethylsilylamide) in THF at -78° C. under a nitrogen atmosphere. The reaction mixture was magnetically stirred at -78° C. for 1 hour, then 174 μL (2.80 mmol) of iodomethane was added via syringe. The reaction was allowed to warm to room temperature and was stirred an additional 14 hours. The reaction was next quenched with excess 10% aqueous NaHSO4 and partitioned between EtOAc and water. The organic layer was washed with saturated aqueous NaCl, dried (MgSO4), filtered and evaporated. The residue was purified on a silica gel flash chromatography column eluted with CHCl3 --MeOH--NH4OH (90:10:1). Evaporation of the purified fractions and drying in vacuo afforded 0.293 g (55%) of the title compound as an amorphous solid.

Aufarbeitung

  1. temperatureto warm to room temperature
  2. stirringwas stirred an additional 14 hours
  3. customThe reaction was next quenched with excess 10% aqueous NaHSO4
  4. custompartitioned between EtOAc and water
  5. washThe organic layer was washed with saturated aqueous NaCl
  6. dry with materialdried (MgSO4)
  7. filtrationfiltered
  8. customevaporated
  9. customThe residue was purified on a silica gel flash chromatography column
  10. washeluted with CHCl3 --MeOH--NH4OH (90:10:1)
  11. customEvaporation of the purified fractions
  12. customdrying in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-4fb625ff0df640e7abb75bc455f83a17
Quelldatensatz
uspto-grants-1997_09
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US05668176

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion